BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26650885)

  • 1. Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.
    Mauck C; Chen PL; Morrison CS; Fichorova RN; Kwok C; Chipato T; Salata RA; Doncel GF
    AIDS Res Hum Retroviruses; 2016 May; 32(5):443-51. PubMed ID: 26650885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.
    Morrison CS; Fichorova R; Chen PL; Kwok C; Deese J; Yamamoto H; Anderson S; Chipato T; Salata R; Doncel GF
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):889-899. PubMed ID: 30047279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
    Morrison C; Fichorova RN; Mauck C; Chen PL; Kwok C; Chipato T; Salata R; Doncel GF
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):109-17. PubMed ID: 24413042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
    Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF
    PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
    Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical and systemic innate immunity predictors of HIV risk linked to genital herpes acquisition and time from HSV-2 seroconversion.
    Govender Y; Morrison CS; Chen PL; Gao X; Yamamoto H; Chipato T; Anderson S; Barbieri R; Salata R; Doncel GF; Fichorova RN
    Sex Transm Infect; 2023 Aug; 99(5):311-316. PubMed ID: 36104248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.
    Morrison CS; Chen PL; Yamamoto H; Gao X; Chipato T; Anderson S; Barbieri R; Salata R; Doncel GF; Fichorova RN
    J Acquir Immune Defic Syndr; 2020 May; 84(1):85-91. PubMed ID: 31985699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
    Mitchell C; Hitti J; Paul K; Agnew K; Cohn SE; Luque AE; Coombs R
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):35-9. PubMed ID: 20929397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.
    Cummins JE; Christensen L; Lennox JL; Bush TJ; Wu Z; Malamud D; Evans-Strickfaden T; Siddig A; Caliendo AM; Hart CE; Dezzutti CS
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):788-95. PubMed ID: 16910835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
    Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C
    mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital inflammation and the risk of HIV acquisition in women.
    Masson L; Passmore JA; Liebenberg LJ; Werner L; Baxter C; Arnold KB; Williamson C; Little F; Mansoor LE; Naranbhai V; Lauffenburger DA; Ronacher K; Walzl G; Garrett NJ; Williams BL; Couto-Rodriguez M; Hornig M; Lipkin WI; Grobler A; Abdool Karim Q; Abdool Karim SS
    Clin Infect Dis; 2015 Jul; 61(2):260-9. PubMed ID: 25900168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.
    Bull ME; Legard J; Tapia K; Sorensen B; Cohn SE; Garcia R; Holte SE; Coombs RW; Hitti JE
    J Acquir Immune Defic Syndr; 2014 Dec; 67(4):357-64. PubMed ID: 25202922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.
    Cohen CR; Moscicki AB; Scott ME; Ma Y; Shiboski S; Bukusi E; Daud I; Rebbapragada A; Brown J; Kaul R
    AIDS; 2010 Aug; 24(13):2069-74. PubMed ID: 20588163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic sexual abuse and depression on inflammation and wound healing in the female reproductive tract of HIV-uninfected and HIV-infected women.
    Ghosh M; Daniels J; Pyra M; Juzumaite M; Jais M; Murphy K; Taylor TN; Kassaye S; Benning L; Cohen M; Weber K
    PLoS One; 2018; 13(6):e0198412. PubMed ID: 29894487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.
    Jais M; Younes N; Chapman S; Cu-Uvin S; Ghosh M
    Am J Obstet Gynecol; 2016 Sep; 215(3):324.e1-324.e10. PubMed ID: 27026477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.
    Homans J; Christensen S; Stiller T; Wang CH; Mack W; Anastos K; Minkoff H; Young M; Greenblatt R; Cohen M; Strickler H; Karim R; Spencer LY; Operskalski E; Frederick T; Kovacs A
    J Acquir Immune Defic Syndr; 2012 May; 60(1):99-110. PubMed ID: 22517416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women.
    Mitchell C; Balkus JE; McKernan-Mullin J; Cohn SE; Luque AE; Mwachari C; Cohen CR; Coombs R; Frenkel LM; Hitti J
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):143-8. PubMed ID: 23018377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.
    Patel EU; Kirkpatrick AR; Grabowski MK; Kigozi G; Gray RH; Prodger JL; Redd AD; Nalugoda F; Serwadda D; Wawer MJ; Quinn TC; Tobian AA
    Clin Infect Dis; 2017 Mar; 64(6):776-784. PubMed ID: 28011606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.